Who are Compound Kushen Injection（CKI）'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): XueBiJing Injection, Abelmoschus manihot (AM).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/compound-kushen-injection-cki.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Compound Kushen Injection（CKI） — Competitive Intelligence Brief

Compound Kushen Injection（CKI） (Compound Kushen Injection（CKI）) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal extract / Traditional Chinese medicine. Area: Oncology.

marketed Herbal extract / Traditional Chinese medicine Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Compound Kushen Injection（CKI） (Compound Kushen Injection（CKI）) — Shanxi Zhendong Pharmacy Co., Ltd. Compound Kushen Injection is a traditional Chinese medicine-derived herbal extract that exerts anti-tumor and immunomodulatory effects through multiple pathways including apoptosis induction and immune system activation.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Compound Kushen Injection（CKI） TARGET	Compound Kushen Injection（CKI）	Shanxi Zhendong Pharmacy Co., Ltd	marketed	Herbal extract / Traditional Chinese medicine
XueBiJing Injection	XueBiJing Injection	Nanjing Medical University	marketed	Herbal extract / Traditional Chinese Medicine
Abelmoschus manihot (AM)	Abelmoschus manihot (AM)	Chinese PLA General Hospital	marketed	Herbal extract / Traditional Chinese Medicine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal extract / Traditional Chinese medicine class)

Shanxi Zhendong Pharmacy Co., Ltd · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Compound Kushen Injection（CKI） — Competitive Intelligence Brief. https://druglandscape.com/ci/compound-kushen-injection-cki. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab